Literature DB >> 18645581

Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes.

D A Shoskes1, J C Nickel, R R Rackley, M A Pontari.   

Abstract

The urologic chronic pain conditions such as chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis are syndromes whose evaluation and management are controversial. Part of the difficulty in diagnosis and therapy is the heterogeneity of etiologies and symptoms. We propose a six-domain phenotype, which can classify these patients clinically and can direct the selection of therapy in the most evidence based multimodal manner. The domains are urinary, psychosocial, organ specific, infection, neurologic and tenderness of skeletal muscles. This system is flexible and responsive to new biomarkers and therapies as their utility and efficacy are proven.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645581     DOI: 10.1038/pcan.2008.42

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  47 in total

1.  A new approach to understanding and managing chronic prostatitis and interstitial cystitis.

Authors:  J Curtis Nicke
Journal:  Rev Urol       Date:  2010

Review 2.  Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Hans C Arora; Charis Eng; Daniel A Shoskes
Journal:  Ann Transl Med       Date:  2017-01

3.  What is BPS and how should it be managed in real life clinical practice?

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

4.  Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada.

Authors:  J Curtis Nickel; Dean Tripp; Allan Gordon; Michel Pontari; Daniel Shoskes; Kenneth M Peters; Ragi Doggweiler; Andrew Paul Baranowski
Journal:  Rev Urol       Date:  2011

5.  CD-163 correlated with symptoms (pain or discomfort) of prostatic inflammation.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Soichi Arakawa; Kazushi Tanaka; Masato Fujisawa
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

6.  Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.

Authors:  Iryna M Crescenze; Barbara Tucky; Jianbo Li; Courtenay Moore; Daniel A Shoskes
Journal:  Urology       Date:  2017-05-18       Impact factor: 2.649

Review 7.  Mechanisms of chronic urologic pain.

Authors:  Christopher Wu; Keith Jarvi
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

Review 8.  Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system.

Authors:  Daniel A Shoskes; J Curtis Nickel
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 9.  [Options for pain therapy of urologic chronic pelvic pain syndrome (UCPPS)].

Authors:  O Moormann
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

10.  Urological symptoms in a subset of patients with urological chronic pelvic pain syndrome and a polysymptomatic, polysyndromic pattern of presentation.

Authors:  H Henry Lai; Carol S North; Gerald L Andriole; Lori Cupps; David Song; Timothy J Ness; Barry A Hong
Journal:  J Urol       Date:  2013-12-19       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.